How to Cite
Downloads
Métricas Alternativas
Dimensions
Abstract
Statins have been widely used for the treatment of hypercholesterolemia and other cardiovascular diseases. Recently, statins have been studied for their apoptotic effects, making them relevant for cancer prevention and treatment; however, their exact mechanisms of action are still unclear. In this study, we used malignant UMR-106 osteosarcoma cells and normal HTR8/SVneo extravillous trophoblast cells, and found that simvastatin decreases cell viability in a dose and time-dependent manner in both cell types. In addition, 10 µM simvastatin was able to induce apoptosis in trophoblast cells, as evaluated by FACS analysis. Finally, proteomic analysis of protein expression suggests a specific regulatory mechanism that could explain some of the anticancer effects of this statin.
Keywords
References
Aberg, M., Wickstrom, M. and Siegbahn, A. 2008. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa, Thromb Res 122(2):191-202.
Arévalo-Ferro, C. 2004. Proteomics View Of Quorum-Sensing Regulated and Surface Induced Genes in Representative Pseudomonas and Burkholderia Species., 128, PhD, Institute of Microbiology of Technischen München, Germany.
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72:248-254.
Cabrera-Benitez, N. E. 2008. Papel de los inhibidores de la 3-hidroxi-3-metilglutaril coenzima A reductasa (estatinas) en las líneas celulares de osteosarcoma. Estudio In vitro., 141, PhD, Departamento de Ciencias Clínicas, Las Palmas de Gran Canaria, Gran Canaria, Spain.
Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchell, J. B. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing, Cancer Res 47(4):936-942.
Casey, P. J. 1992. Biochemistry of protein prenylation, J Lipid Res 33(12):1731-1740.
Demierre, M. F., Higgins, P. D., Gruber, S. B., Hawk, E. and Lippman, S. M. 2005. Statins and cancer prevention. Nat Rev Cancer 5(12):930-942.
Gauthaman, K., Manasi, N. and Bongso, A. 2009. Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells. Br J Pharmacol 157(6):962-973.
Gronich, N., Drucker, L., Shapiro, H., Radnay, J., Yarkoni, S. and Lishner, M., 2004. Simvastatin induces death of multiple myeloma cell lines, J Investig Med 52(5):335-344.
Guerrero, M., Di Giulio, C. and De Sanctis, J. B. 2010. Las estatinas afectan la viabilidad de líneas celulares de leucemia y linfoma humanas in vitro, Revista de la Facultad de Medicina 33(1):11-14.
Heare, T., Hensley, M. A. and Dell'Orfano, S. 2009. Bone tumors: osteosarcoma and Ewing's sarcoma, Curr Opin Pediatr 21(3):365-372.
Hoque, A., Chen, H. and Xu, X. C. 2008. Statin induces apoptosis and cell growth arrest in prostate cancer cells, Cancer Epidemiol Biomarkers Prev 17(1):88-94.
Kang, W. K., Lee, I., Ko, U. and Park, C. 2005. Differential effects of RhoA signaling on anticancer agent-induced cell death, Oncol Rep 13(2):299-304.
Kenis, I., Tartakover-Matalon, S., Cherepnin, N., Drucker, L., Fishman, A., Pomeranz, M. and Lishner, M. 2005. Simvastatin has deleterious effects on human first trimester placental explants, Hum Reprod 20(10):2866-2872.
Kidera, Y., Tsubaki, M., Yamazoe, Y., Shoji, K., Nakamura, H., Ogaki, M., Satou, T., Itoh, T., Isozaki, M., Kaneko, J., Tanimori, Y., Yanae, M. and Nishida, S. 2010. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway, J Exp Clin Cancer Res 29: 127.
Koyuturk, M., Ersoz, M. and Altiok, N. 2004. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase, Neurosci Lett 370(2-3):212-217.
Koyuturk, M., Ersoz, M. and Altiok, N. 2007. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK, Cancer Lett 250(2):220-228.
Larsson, O. 1996. HMG-CoA reductase inhibitors: role in normal and malignant cells, Crit Rev Oncol Hematol 22(3):197-212.
Mueck, A. O., Seeger, H. and Wallwiener, D. 2003. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells, Menopause 10(4):332-336.
Riganti, C., Aldieri, E., Doublier, S., Bosia, A. and Ghigo, D. 2008. Statins-mediated inhibition of rho GTPases as a potential tool in anti-tumor therapy, Mini Rev Med Chem 8(6):609-618.
Sandoval-Usme, M. C., Umaña-Pérez, A., García-Castellano, J. M., Fernández-Pérez, L. F. and Sánchez-Gómez, M. 2010. OR5,28 GH-induced activation of JAK/STAT signaling in osteosarcoma cells is inhibited by statins through the induction of SOCS expression, Growth Hormone and IGF Research, 20(1 (supplemented))S13-S13.
Sinensky, M. 2000. Recent advances in the study of prenylated proteins, Biochim Biophys Acta 1484(2-3):93-106.
Siperstein, M. D. 1984. Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth, J Lipid Res 25(13)1462-1468.
Stamm, J. A. and Ornstein, D. L. 2005. The role of statins in cancer prevention and treatment, Oncology (Williston Park), 19(6):739-750; discussion 753-734.
Wong, W. W., Dimitroulakos, J., Minden, M. D. and Penn, L. Z. 2002. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis, Leukemia 16(4)508-519.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 https://creativecommons.org/licenses/by-nc-nd/4.0